Approach
Team
News
Portfolio
Apply for funding
en
de
BioGenes
Providing specialized immunoassay development and antibody services for the global biotech industry.
Exit: 2015 Secondary Transaction
invested since
2003
website
social media
↙ Back to Portfolio
